Sodium phosphate, dibasic, unspecified form

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Sodium phosphate, dibasic, unspecified form
Accession Number
DB14504
Type
Small Molecule
Groups
Approved, Experimental
Description
Not Available
Synonyms
  • Sodium phosphate, dibasic, unspecified
Active Moieties
NameKindUNIICASInChI Key
Phosphoric acidunknownE4GA8884NN7664-38-2NBIIXXVUZAFLBC-UHFFFAOYSA-N
Sodium cationionicLYR4M0NH3717341-25-2FKNQFGJONOIPTF-UHFFFAOYSA-N
Phosphate ionionicNK08V8K8HR14265-44-2NBIIXXVUZAFLBC-UHFFFAOYSA-K
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
AminosynSodium phosphate, dibasic, unspecified form (425 mg/100mL) + Alanine (1100 mg/100mL) + Arginine (850 mg/100mL) + Glycine (1100 mg/100mL) + Histidine (260 mg/100mL) + Isoleucine (620 mg/100mL) + L-Lysine acetate (624 mg/100mL) + Leucine (810 mg/100mL) + Magnesium chloride hexahydrate (102 mg/100mL) + Methionine (340 mg/100mL) + Phenylalanine (380 mg/100mL) + Potassium chloride (487 mg/100mL) + Proline (750 mg/100mL) + Serine (370 mg/100mL) + Sodium chloride (28 mg/100mL) + Threonine (460 mg/100mL) + Tryptophan (150 mg/100mL) + Tyrosine (44 mg/100mL) + Valine (680 mg/100mL)Injection, solutionIntravenousHospira, Inc.2011-03-23Not applicableUs
AminosynSodium phosphate, dibasic, unspecified form (425 mg/100mL) + Alanine (900 mg/100mL) + Arginine (690 mg/100mL) + Glycine (900 mg/100mL) + Histidine (210 mg/100mL) + Isoleucine (510 mg/100mL) + L-Lysine acetate (510 mg/100mL) + Leucine (660 mg/100mL) + Magnesium chloride hexahydrate (102 mg/100mL) + Methionine (280 mg/100mL) + Phenylalanine (310 mg/100mL) + Potassium chloride (487 mg/100mL) + Proline (610 mg/100mL) + Serine (300 mg/100mL) + Sodium chloride (28 mg/100mL) + Threonine (370 mg/100mL) + Tryptophan (120 mg/100mL) + Tyrosine (44 mg/100mL) + Valine (560 mg/100mL)Injection, solutionIntravenousHospira, Inc.2011-03-23Not applicableUs
Aminosyn II in DextroseSodium phosphate, dibasic, unspecified form (49.3 mg/100mL) + Alanine (348 mg/100mL) + Arginine (356 mg/100mL) + Aspartic acid (245 mg/100mL) + D-glucose monohydrate (5 g/100mL) + Glutamic acid (258 mg/100mL) + Glycine (175 mg/100mL) + Histidine (105 mg/100mL) + Isoleucine (231 mg/100mL) + L-Lysine acetate (368 mg/100mL) + Leucine (350 mg/100mL) + Magnesium chloride hexahydrate (30 mg/100mL) + Methionine (60 mg/100mL) + N-acetyltyrosine (94 mg/100mL) + Phenylalanine (104 mg/100mL) + Potassium chloride (97 mg/100mL) + Proline (252 mg/100mL) + Serine (186 mg/100mL) + Sodium chloride (120 mg/100mL) + Threonine (140 mg/100mL) + Tryptophan (70 mg/100mL) + Valine (175 mg/100mL)Injection, solutionIntravenousHospira, Inc.1988-11-012010-01-01Us
Aminosyn II with ElectrolytesSodium phosphate, dibasic, unspecified form (425 mg/100mL) + Alanine (844 mg/100mL) + Arginine (865 mg/100mL) + Aspartic acid (595 mg/100mL) + Glutamic acid (627 mg/100mL) + Glycine (425 mg/100mL) + Histidine (255 mg/100mL) + Isoleucine (561 mg/100mL) + L-Lysine acetate (893 mg/100mL) + Leucine (850 mg/100mL) + Magnesium chloride hexahydrate (102 mg/100mL) + Methionine (146 mg/100mL) + N-acetyltyrosine (230 mg/100mL) + Phenylalanine (253 mg/100mL) + Potassium chloride (492 mg/100mL) + Proline (614 mg/100mL) + Serine (450 mg/100mL) + Sodium chloride (60 mg/100mL) + Threonine (340 mg/100mL) + Tryptophan (170 mg/100mL) + Valine (425 mg/100mL)Injection, solutionIntravenousHospira, Inc.1986-04-03Not applicableUs
Bss PlusSodium phosphate, dibasic, unspecified form (0.433 mg/1mL) + Calcium chloride dihydrate (3.85 mg/1mL) + Dextrose, unspecified form (23 mg/1mL) + Glutathione disulfide (4.6 mg/1mL) + Magnesium chloride hexahydrate (5 mg/1mL) + Potassium chloride (0.395 mg/1mL) + Sodium bicarbonate (2.19 mg/1mL) + Sodium chloride (7.44 mg/1mL)OphthalmicALCON LABORATORIES, INC.2013-06-20Not applicableUs
Care One EnemaSodium phosphate, dibasic, unspecified form (7 g/118mL) + Sodium phosphate, monobasic, unspecified form (19 g/118mL)EnemaRectalAmerican Sales Company2010-01-182014-06-07Us
Curad Oral Saline LaxativeSodium phosphate, dibasic, unspecified form (2.9 g/15mL) + Sodium phosphate, monobasic, unspecified form (7.2 g/15mL)LiquidOralMedline Industries2012-07-162016-12-31Us
Curad Oral Saline LaxativeSodium phosphate, dibasic, unspecified form (2.9 g/15mL) + Sodium phosphate, monobasic, unspecified form (7.2 g/15mL)LiquidOralMedline Industries2012-07-162016-12-31Us
Curad Saline LaxativeSodium phosphate, dibasic, unspecified form (7 g/118mL) + Sodium phosphate, monobasic, unspecified form (19 g/118mL)EnemaRectalMedline Industries2012-07-16Not applicableUs
CVS PharmacySodium phosphate, dibasic, unspecified form (3.5 g/59mL) + Sodium phosphate, monobasic, unspecified form (9.5 g/59mL)EnemaRectalCVS Health2014-05-20Not applicableUs
Categories
UNII
GR686LBA74
CAS number
10140-65-5

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Sodium phosphate, dibasic, unspecified form.
AclidiniumThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Aclidinium.
AgmatineThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Agmatine.
AlcuroniumThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Alcuronium.
AlfentanilThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Sodium phosphate, dibasic, unspecified form is combined with Alloin.
AlmasilateThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Almasilate.
AloglutamolThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Aloglutamol.
AlphacetylmethadolThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Alphacetylmethadol.
AlphaprodineThe therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Alphaprodine.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedNot AvailableHealthy Volunteers1
3Unknown StatusTreatmentMalnutrition1
4CompletedOtherSickle Cell Disorders1
4Not Yet RecruitingBasic ScienceHeart Defects,Congenital1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, solutionIntravenous
LiquidRectal
SolutionIntravenous
LiquidOral
SolutionExtracorporeal
EnemaRectal
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on July 11, 2018 15:12 / Updated on March 01, 2020 21:51

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates